x 

0 Activities
0 Activities
    • No Saved Activities

Webinars

  2. Home
  3. Education
  4. Format
  5. Webinars
  6. PILOTforPulmonary.org

Search

Saved Activities

 x 

0 Activities
0 Activities
    • No Saved Activities

Filter Content

PILOTforPulmonary.org

PILOT provides comprehensive continuing medical education, supporting the diagnosis and management patients for various pulmonary diseases.

Page 1 of 3
Results 1 - 75 of 209
9194 chILD module
Childhood ILD: Increasing Awareness, Diagnosis, & Patient Management
9263 NCFBE
The Burden of Bronchiectasis: A Focus on NCFBE Pathophysiology
9165 pneumo explore
Utilizing ACIP's Updated Pneumococcal Recommendations
9165 product
Utilizing ACIP's Updated Pneumococcal Recommendations - Rapid Recap
9157-0003-slide263x149
NTM-LD Daignosis and Management - Slides
No image set
ILD Patient Case Library: IPF, PF-ILD, SSc-ILD, and Post COVID-19
9089_nsclc_titleslide
TARGET for NSCLC: Genomic Pathways and Use of EGFR Therapies
No image set
PAH: Risk Reduction Strategies Using Single and Combination Therapies
9102-chest-slides
Slides: IPF Management and Antifibrotic Therapy
9088-covid-slides
Slides: Post COVID-19 and Patients With and Without Pre-existing ILD
9088-ipf-slides
Slides: A Collaborative Approach to IPF Management
9088-sscild-slides
Slides: Practical Solutions to SSc-ILD Treatment
No image set
Improved Patient Outcomes in PAH
9088-pfild-slides8
Slides: A New Paradigm in Treating ILD
9101-chest
IPF Management and Antifibrotic Therapy
No image set
How to Develop an Effective Risk Reduction Strategy in Pulmonary Arterial Hypertension
No image set
Pulmonary Arterial Hypertension (PAH) - Therapy Options Explained
No image set
EXPLORE Learning Experience: COVID-19 and Monoclonal Antibodies
No image set
EXPLORE Learning Experience: Understanding and Managing NTM-Lung Disease
No image set
A New Paradigm in Treating ILD
No image set
A Collaborative Approach to IPF Management
No image set
Practical Solutions to SSc-ILD Treatment
No image set
Post COVID-19 and Patients With and Without Pre-existing ILD
No image set
PAH: Aligning Treatment Strategy to Risk Level
No image set
Patient Develops de novo Features of ILD After a COVID Infection
No image set
SSc-ILD Individualized Treatment
No image set
Overlapping Symptoms and Risk Factors for COVID and IPF
No image set
Multidisciplinary Management of IPF
No image set
Fundamentals of Diagnosis: SSc-ILD
No image set
Fundamentals of Diagnosis: PF-ILD
No image set
Beyond The Basics Of PAH
No image set
COVID-19 Acute and Long-term Lung Injury
No image set
COVID-19: An Animated Video Series
No image set
COVID-19 and ARDS: East Coast Experiences
No image set
End of Life in IPF
No image set
Comprehensive Care of the ILD Patient–Focus on Symptoms
No image set
Developing an Action Plan
No image set
Diagnosis of Interstitial Lung Disease
No image set
Management of Patients With IPF: Virtual Conference Coverage
No image set
Allergic Asthma: Virtual Conference Coverage
No image set
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
No image set
New Directions in the Diagnosis of RA ILD
No image set
Therapies on the Horizon for RA ILD
No image set
New Treatment Options for SSc ILD
No image set
Updates on Current Treatment Options for RA ILD
No image set
Practical Questions in the Diagnosis and Management of Patients With MAC
No image set
EULAR 2020 Conference Coverage
No image set
COVID-19 and ARDS: West Coast Experiences
No image set
Biochemical Profiles of Radiographic Patterns in SSc-ILD
No image set
Factors Associated with Disease Progression in the SENSCIS Trial
No image set
Machine Learning Assisted Prediction of Progression in SSc-ILD
No image set
What Have We Learned from Clinical Trials on Sex Differences in SSc-ILD
No image set
Efficacy of MMF in African Americans vs Non-African Americans with SSc-ILD
No image set
Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis
No image set
Updates on Current Treatment Options for RA-ILD
cc4
Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib
No image set
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
No image set
PILOTforPulmonary 2019: Data, Insights & Practice
No image set
Managing the Whole Patient with COPD: An Animated Video Series
No image set
My COPD Action Plan
No image set
Expert Recommendations for COPD
No image set
Surgical and Minimally Invasive Procedures that Might Benefit COPD Patients
No image set
COPD: Fixed Dose Combinations
No image set
COPD: Proper Inhaler Use
No image set
Clinical Pearls from New Orleans 2019
No image set
Inhaled NO in Patients at Risk for Pulmonary Hypertension
No image set
Nintedanib for Patients with Systemic Sclerosis-Related Interstitial Lung Disease
No image set
Considerations for Geriatric ILD Patients
No image set
Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease
No image set
Emerging Diagnostic Approaches to Patients with ILD
No image set
Goals of Care Across the Disease Continuum in IPF
No image set
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
No image set
Current Perspective on Antifibrotic Therapy for Patients with IPF
No image set
Pulmonologists as the Gatekeepers of Precision Medicine
No image set
Interstitial Pneumonia with Autoimmune Features (IPAF)
Page 1 of 3

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

Chandler Building, 84 Lyme Street, Old Lyme, CT USA

Search